Compare PKE & SMTI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | PKE | SMTI |
|---|---|---|
| Founded | 1954 | 1982 |
| Country | United States | United States |
| Employees | N/A | 108 |
| Industry | Military/Government/Technical | Medical/Dental Instruments |
| Sector | Industrials | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 635.0M | 205.6M |
| IPO Year | 1994 | 2008 |
| Metric | PKE | SMTI |
|---|---|---|
| Price | $32.29 | $22.13 |
| Analyst Decision | | Strong Buy |
| Analyst Count | 0 | 2 |
| Target Price | N/A | ★ $34.00 |
| AVG Volume (30 Days) | ★ 232.0K | 39.7K |
| Earning Date | 05-15-2026 | 05-12-2026 |
| Dividend Yield | ★ 1.53% | N/A |
| EPS Growth | ★ 93.10 | N/A |
| EPS | ★ 0.56 | 0.05 |
| Revenue | N/A | ★ $15,586,976.00 |
| Revenue This Year | N/A | $17.31 |
| Revenue Next Year | N/A | $12.48 |
| P/E Ratio | ★ $58.79 | $442.40 |
| Revenue Growth | N/A | ★ 32.47 |
| 52 Week Low | $13.53 | $16.05 |
| 52 Week High | $38.20 | $35.70 |
| Indicator | PKE | SMTI |
|---|---|---|
| Relative Strength Index (RSI) | 45.86 | 54.87 |
| Support Level | $31.27 | $18.20 |
| Resistance Level | $35.58 | $24.17 |
| Average True Range (ATR) | 2.08 | 1.23 |
| MACD | -0.33 | -0.20 |
| Stochastic Oscillator | 27.10 | 40.78 |
Park Aerospace Corp designs is an aerospace company which develops and manufactures solution and hot-melt composite materials used to produce composite structures for the aerospace markets. Its composite materials include film adhesives and lightning strike protection materials. Its composite materials are used to produce primary and secondary structures for jet engines, large and regional transport aircraft, military aircraft, Unmanned Aerial Vehicles (UAVs commonly referred to as drones), business jets, general aviation aircraft and rotary wing aircraft. The Company's products are sold to customers in North America, Asia and Europe.
Sanara MedTech Inc is a medical technology company focused on developing and commercializing technologies to improve clinical outcomes and reduce healthcare expenditures in the surgical market. It markets and sells soft tissue repair and bone fusion products for use in operating rooms and sterile environments. Its soft tissue repair products include CellerateRX Surgical Powder, a hydrolyzed collagen used in management of surgical wounds, and BIASURGE Surgical Solution, a sterile no-rinse solution for wound irrigation, while its bone fusion products include BiFORM Bioactive Moldable Matrix, an osteoconductive implant that supports bone growth, and ALLOCYTE Plus Viable Bone Matrix, a human allograft cellular bone matrix containing bone-derived progenitor cells and conformable bone fibers.